OrthoAccel Technologies, Inc., a Houston, Texas-based manufacturer of AcceleDent, a noninvasive FDA-cleared, Class II medical device that speeds up orthodontic treatment, closed on a $5m equity financing.
Backers included HealthpointCapital and S3 Ventures.
The company intends to use the funds to expand its sales force and support its growth.
Led by Michael K. Lowe, president and CEO, OrthoAccel is medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. Its AcceleDent® is a FDA-cleared clinical device that accelerates orthodontic tooth movement by applying gentle micropulses as a complement to existing orthodontic treatment. It is now available in more than 2,000 orthodontic locations in the U.S.